← FDA DRUG APPROVALS

FDA ANDA · ANDA071325

CLORPRES

Sponsor: NATCO PHARMA

APPLICATION
ANDA071325
TYPE
ANDA
ORIGINAL APPROVAL
1987-02-09
LATEST ACTION
2002-08-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLORPRESDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.3MG · TABLET · ORAL
CLORPRESDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.2MG · TABLET · ORAL
CLORPRESDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.1MG · TABLET · ORAL

Approval history

2002-08-22Manufacturing (CMC) · Supplement 14AP
1999-12-10Manufacturing (CMC) · Supplement 12AP
1998-12-11Labeling · Supplement 13AP
1998-10-16Labeling · Supplement 11AP
1998-02-05Manufacturing (CMC) · Supplement 10AP
1995-03-03Manufacturing (CMC) · Supplement 9AP
1993-10-15Manufacturing (CMC) · Supplement 7AP
1990-01-31Manufacturing (CMC) · Supplement 6AP
1989-08-23Labeling · Supplement 5AP
1989-05-24Manufacturing (CMC) · Supplement 4AP
1988-04-13Labeling · Supplement 3AP
1988-04-01Labeling · Supplement 2AP
1987-06-23Manufacturing (CMC) · Supplement 1AP
1987-02-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →